These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 20860547)

  • 1. Current and new cytomegalovirus antivirals and novel animal model strategies.
    McGregor A
    Inflamm Allergy Drug Targets; 2010 Sep; 9(4):286-99. PubMed ID: 20860547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus antivirals and development of improved animal models.
    McGregor A; Choi KY
    Expert Opin Drug Metab Toxicol; 2011 Oct; 7(10):1245-65. PubMed ID: 21883024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral treatment of cytomegalovirus infection.
    Ahmed A
    Infect Disord Drug Targets; 2011 Oct; 11(5):475-503. PubMed ID: 21827432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical aspects of cytomegalovirus antiviral resistance in solid organ transplant recipients.
    Le Page AK; Jager MM; Iwasenko JM; Scott GM; Alain S; Rawlinson WD
    Clin Infect Dis; 2013 Apr; 56(7):1018-29. PubMed ID: 23243176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of cytomegalovirus infections beyond acute disease to improve human health.
    Söderberg-Nauclér C
    Expert Rev Anti Infect Ther; 2014 Feb; 12(2):211-22. PubMed ID: 24404994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticytomegalovirus Peptides Point to New Insights for CMV Entry Mechanisms and the Limitations of
    Jackson JW; Hancock TJ; Dogra P; Patel R; Arav-Boger R; Williams AD; Kennel SJ; Wall JS; Sparer TE
    mSphere; 2019 Feb; 4(1):. PubMed ID: 30760613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence and persistence of multiple antiviral-resistant CMV strains in a highly immunocompromised child.
    Iwasenko JM; Scott GM; Ziegler JB; Rawlinson WD
    J Clin Virol; 2007 Oct; 40(2):152-5. PubMed ID: 17698411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Letermovir for the management of cytomegalovirus infection.
    Bowman LJ; Melaragno JI; Brennan DC
    Expert Opin Investig Drugs; 2017 Feb; 26(2):235-241. PubMed ID: 27998189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical relevance of cytomegalovirus infection in patients with disorders of the immune system.
    Steininger C
    Clin Microbiol Infect; 2007 Oct; 13(10):953-63. PubMed ID: 17803749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HCMV Antivirals and Strategies to Target the Latent Reservoir.
    Perera MR; Wills MR; Sinclair JH
    Viruses; 2021 May; 13(5):. PubMed ID: 34062863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and treatment of cytomegalovirus infection in organ transplant recipients.
    Kusne S; Shapiro R; Fung J
    Transpl Infect Dis; 1999 Sep; 1(3):187-203. PubMed ID: 11428989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral Agents as Therapeutic Strategies Against Cytomegalovirus Infections.
    Chen SJ; Wang SC; Chen YC
    Viruses; 2019 Dec; 12(1):. PubMed ID: 31878068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis and characterization of antiviral drug-resistant cytomegalovirus isolates from solid organ transplant recipients.
    Lurain NS; Bhorade SM; Pursell KJ; Avery RK; Yeldandi VV; Isada CM; Robert ES; Kohn DJ; Arens MQ; Garrity ER; Taege AJ; Mullen MG; Todd KM; Bremer JW; Yen-Lieberman B
    J Infect Dis; 2002 Sep; 186(6):760-8. PubMed ID: 12198609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expanding role of cytomegalovirus as a human pathogen.
    Navarro D
    J Med Virol; 2016 Jul; 88(7):1103-12. PubMed ID: 26681168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of multidrug-resistant CMV infection in immunocompromised patients: case report of a heart-transplant recipient and review of the literature.
    Deback C; Burrel S; Varnous S; Carcelain G; Conan F; Aït-Arkoub Z; Autran B; Gandjbakhch I; Agut H; Boutolleau D
    Antivir Ther; 2015; 20(2):249-54. PubMed ID: 25219330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diversity of antiviral-resistant human cytomegalovirus in heart and lung transplant recipients.
    Iwasenko JM; Scott GM; Naing Z; Glanville AR; Rawlinson WD
    Transpl Infect Dis; 2011 Apr; 13(2):145-53. PubMed ID: 21070537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent strategies in the development of new human cytomegalovirus inhibitors.
    Martinez A; Castro A; Gil C; Perez C
    Med Res Rev; 2001 May; 21(3):227-44. PubMed ID: 11301412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pivotal role of animal models in the development of new therapies for cytomegalovirus infections.
    Kern ER
    Antiviral Res; 2006 Sep; 71(2-3):164-71. PubMed ID: 16828175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary involvement during cytomegalovirus infection in immunosuppressed patients.
    de Maar EF; Verschuuren EA; Harmsen MC; The TH; van Son WJ
    Transpl Infect Dis; 2003 Sep; 5(3):112-20. PubMed ID: 14617298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approach to drug-resistant cytomegalovirus in transplant recipients.
    Chou S
    Curr Opin Infect Dis; 2015 Aug; 28(4):293-9. PubMed ID: 26098499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.